2020-12-03 08:21
Overview Target Drug Modality Indication Mechanism of Action Status Data Drug Name H-05 Description The hepatitis B virus (HBV) belongs to oncogenic viruses that cause hepatocellular cancer (HCC). The global prevalence of hepatitis B infection was es
... дальше

2020-12-03 08:21
Overview Target Indication Mechanism of Action Status Data Drug Name Angiocidin Description Angiocidin a 41 kDa recombinant human protein that binds to the TNF superfamily death receptor 6 (DR6) to drive differentiation of leukemic cells and activate
... дальше

2020-12-03 08:21
Overview Target Drug Modality Indication Mechanism of Action Status Data Drug Name MB-X01Y03 Description Mitochondria are at the center of cellular metabolism. Alteration in mitochondrial function causally contributes to many diseases. It has long be
... дальше

2020-12-03 08:20
At Protheragen, we help out-license and find co-development opportunities for drug development programs. We aspire to play a role in transforming the scientific innovations into medications, helping patients with the most challenging diseases. Our ma
... дальше

2020-12-03 08:20
Overview Key technology Application Status Usage Description A complete pentapeptide library containing over 0.5 billion peptide sequences is an invaluable platform to screen for potential candidates during the process of drug discovery. The cyclic p
... дальше